Sartorius AG (SRT3) Given Average Rating of “Hold” by Analysts

Sartorius AG (FRA:SRT3) has been given a consensus rating of “Hold” by the ten brokerages that are currently covering the company, MarketBeat reports. Three investment analysts have rated the stock with a sell rating, five have issued a hold rating and two have given a buy rating to the company. The average 12-month price target among brokerages that have updated their coverage on the stock in the last year is €78.40 ($93.33).

SRT3 has been the subject of several recent research reports. Berenberg Bank set a €90.00 ($107.14) price target on Sartorius and gave the stock a “buy” rating in a report on Wednesday, September 20th. Commerzbank set a €87.00 ($103.57) price target on Sartorius and gave the stock a “neutral” rating in a report on Tuesday, October 17th. Deutsche Bank set a €88.00 ($104.76) price target on Sartorius and gave the stock a “neutral” rating in a report on Tuesday, October 17th. Oddo Bhf set a €72.00 ($85.71) price target on Sartorius and gave the stock a “sell” rating in a report on Tuesday, October 17th. Finally, Warburg Research set a €100.00 ($119.05) price target on Sartorius and gave the stock a “buy” rating in a report on Tuesday, October 17th.

Shares of Sartorius (FRA SRT3) opened at €87.15 ($103.75) on Monday. Sartorius has a one year low of €63.72 ($75.86) and a one year high of €94.00 ($111.90). The stock has a market cap of $6,620.00 and a P/E ratio of 70.85.

COPYRIGHT VIOLATION WARNING: This piece was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this piece on another domain, it was illegally copied and republished in violation of US and international copyright and trademark legislation. The correct version of this piece can be read at https://www.dispatchtribunal.com/2018/01/15/sartorius-ag-srt3-given-average-rating-of-hold-by-analysts.html.

About Sartorius

Sartorius Aktiengesellschaft provides laboratory and process technologies and equipment worldwide. The company operates through two divisions, Bioprocess Solutions, and Lab Products & Services. The Bioprocess Solutions division offers products, technologies, and services ranging from fermentation, cell cultivation, filtration, and purification to media storage and transportation for the biopharmaceutical industry.

Analyst Recommendations for Sartorius (FRA:SRT3)

Receive News & Ratings for Sartorius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply